233 related articles for article (PubMed ID: 25233928)
1. Transcriptome analysis of pancreatic cancer reveals a tumor suppressor function for HNF1A.
Hoskins JW; Jia J; Flandez M; Parikh H; Xiao W; Collins I; Emmanuel MA; Ibrahim A; Powell J; Zhang L; Malats N; Bamlet WR; Petersen GM; Real FX; Amundadottir LT
Carcinogenesis; 2014 Dec; 35(12):2670-8. PubMed ID: 25233928
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte nuclear factor 1A (HNF1A) as a possible tumor suppressor in pancreatic cancer.
Luo Z; Li Y; Wang H; Fleming J; Li M; Kang Y; Zhang R; Li D
PLoS One; 2015; 10(3):e0121082. PubMed ID: 25793983
[TBL] [Abstract][Full Text] [Related]
3. Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer.
Zhang G; He P; Tan H; Budhu A; Gaedcke J; Ghadimi BM; Ried T; Yfantis HG; Lee DH; Maitra A; Hanna N; Alexander HR; Hussain SP
Clin Cancer Res; 2013 Sep; 19(18):4983-93. PubMed ID: 23918603
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-32 expression in the pancreas.
Nishida A; Andoh A; Inatomi O; Fujiyama Y
J Biol Chem; 2009 Jun; 284(26):17868-76. PubMed ID: 19386602
[TBL] [Abstract][Full Text] [Related]
5. HNF1A recruits KDM6A to activate differentiated acinar cell programs that suppress pancreatic cancer.
Kalisz M; Bernardo E; Beucher A; Maestro MA; Del Pozo N; Millán I; Haeberle L; Schlensog M; Safi SA; Knoefel WT; Grau V; de Vas M; Shpargel KB; Vaquero E; Magnuson T; Ortega S; Esposito I; Real FX; Ferrer J
EMBO J; 2020 May; 39(9):e102808. PubMed ID: 32154941
[TBL] [Abstract][Full Text] [Related]
6. A GNAS mutation found in pancreatic intraductal papillary mucinous neoplasms induces drastic alterations of gene expression profiles with upregulation of mucin genes.
Komatsu H; Tanji E; Sakata N; Aoki T; Motoi F; Naitoh T; Katayose Y; Egawa S; Unno M; Furukawa T
PLoS One; 2014; 9(2):e87875. PubMed ID: 24498386
[TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma.
Janky R; Binda MM; Allemeersch J; Van den Broeck A; Govaere O; Swinnen JV; Roskams T; Aerts S; Topal B
BMC Cancer; 2016 Aug; 16():632. PubMed ID: 27520560
[TBL] [Abstract][Full Text] [Related]
8. Key role of dual specificity kinase TTK in proliferation and survival of pancreatic cancer cells.
Kaistha BP; Honstein T; Müller V; Bielak S; Sauer M; Kreider R; Fassan M; Scarpa A; Schmees C; Volkmer H; Gress TM; Buchholz M
Br J Cancer; 2014 Oct; 111(9):1780-7. PubMed ID: 25137017
[TBL] [Abstract][Full Text] [Related]
9. A potential prognostic marker and therapeutic target: SPOCK1 promotes the proliferation, metastasis, and apoptosis of pancreatic ductal adenocarcinoma cells.
Li J; Ke J; Fang J; Chen JP
J Cell Biochem; 2020 Jan; 121(1):743-754. PubMed ID: 31478239
[TBL] [Abstract][Full Text] [Related]
10. Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma.
Liu Q; Chen J; Wang J; Amos C; Killary AM; Sen S; Wei C; Frazier ML
Mol Carcinog; 2014 Sep; 53(9):711-21. PubMed ID: 23661430
[TBL] [Abstract][Full Text] [Related]
11. The clinical significance and regulation mechanism of hypoxia-inducible factor-1 and miR-191 expression in pancreatic cancer.
Song Z; Ren H; Gao S; Zhao X; Zhang H; Hao J
Tumour Biol; 2014 Nov; 35(11):11319-28. PubMed ID: 25119596
[TBL] [Abstract][Full Text] [Related]
12. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
[TBL] [Abstract][Full Text] [Related]
13. HNF1A regulates oxaliplatin resistance in pancreatic cancer by targeting 53BP1.
Xia R; Hu C; Ye Y; Zhang X; Li T; He R; Zheng S; Wen X; Chen R
Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36825600
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.
Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK
Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992
[TBL] [Abstract][Full Text] [Related]
15. Kif20a inhibition reduces migration and invasion of pancreatic cancer cells.
Stangel D; Erkan M; Buchholz M; Gress T; Michalski C; Raulefs S; Friess H; Kleeff J
J Surg Res; 2015 Jul; 197(1):91-100. PubMed ID: 25953216
[TBL] [Abstract][Full Text] [Related]
16. FOXC2 is up-regulated in pancreatic ductal adenocarcinoma and promotes the growth and migration of cancer cells.
Cui L; Dang S; Qu J; Mao Z; Wang X; Zhang J; Chen J
Tumour Biol; 2016 Jul; 37(7):8579-85. PubMed ID: 26733175
[TBL] [Abstract][Full Text] [Related]
17. Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma.
Wong MH; Xue A; Julovi SM; Pavlakis N; Samra JS; Hugh TJ; Gill AJ; Peters L; Baxter RC; Smith RC
Clin Cancer Res; 2014 Aug; 20(15):4047-58. PubMed ID: 24895459
[TBL] [Abstract][Full Text] [Related]
18. Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients.
Guo S; Jing W; Hu X; Zhou X; Liu L; Zhu M; Yin F; Chen R; Zhao J; Guo Y
Int J Cancer; 2014 Mar; 134(6):1369-78. PubMed ID: 24037692
[TBL] [Abstract][Full Text] [Related]
19. Sirtuin-1 regulates acinar-to-ductal metaplasia and supports cancer cell viability in pancreatic cancer.
Wauters E; Sanchez-Arévalo Lobo VJ; Pinho AV; Mawson A; Herranz D; Wu J; Cowley MJ; Colvin EK; Njicop EN; Sutherland RL; Liu T; Serrano M; Bouwens L; Real FX; Biankin AV; Rooman I
Cancer Res; 2013 Apr; 73(7):2357-67. PubMed ID: 23370328
[TBL] [Abstract][Full Text] [Related]
20. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
